Recent Updates
Recently added Catalysts
ESPR

Esperion to Participate in Upcoming September Investor Conferences

Key Takeaway: ANN ARBOR, Mich., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO, Sheldon Koenig, will present at Morgan Stanley’s 20th Annual Global Healthcare Conference and also participate in H.C. Wainwright’s Annual Global Investment Confere

Full Press Release Details

ANN ARBOR, Mich., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO, Sheldon Koenig, will present at Morgan Stanley’s 20th Annual Global Healthcare Conference and also participate in H.C. Wainwright’s Annual Global Investment Conference.
Event: Morgan Stanley 20 th Annual Global Healthcare Conference
Date: Monday, September 12 th , 2022
Time: 9:20 AM (ET)
Format: Presentation and 1:1 Meetings
Webcast: Link
Event: H.C. Wainwright Annual Global Investment Conference
Date: September 12-14, 2022
Time: Presentation on Sept 13, 11:30 AM (ET)
Format: Presentation and 1:1 Meetings
Webcast Link
A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.esperion.com/investor-relations/events. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company’s website for approximately 90 days.
Esperion Therapeutics
Esperion Corporate Communications

Tags

Last updated: Aug 30, 2022